Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stéphane Bancel
Pharma
Moderna outlines 3-year business strategy in bid to break even
In an effort to break even by 2028, mRNA specialist Moderna is laying out a three-year business strategy aiming to lift revenue by up to 10% in 2026.
Fraiser Kansteiner
Nov 20, 2025 2:54pm
Moderna recorded better-than-expected COVID shot sales in Q2
Aug 1, 2025 11:00am
Moderna plans to lay off 10% of its global workforce this year
Jul 31, 2025 9:50am
Moderna CEO Stéphane Bancel collects highest annual pay, $19.8M
Mar 12, 2025 4:20pm
BioNTech CEO scored €260M payday by exercising stock options
Mar 10, 2025 3:33pm
Moderna trims digital team amid company-wide cost cuts
Feb 13, 2025 3:30pm
